Vildagliptin / Metformin hydrochloride Accord الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Vildagliptin/Metformin Krka 50 mg / 1000 mg النرويج - النرويجية - Statens legemiddelverk

vildagliptin/metformin krka 50 mg / 1000 mg

krka, d.d. novo mesto - vildagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg

Vildagliptin/Metformin Krka 50 mg / 850 mg النرويج - النرويجية - Statens legemiddelverk

vildagliptin/metformin krka 50 mg / 850 mg

krka, d.d. novo mesto - vildagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg

Vildagliptin/Metformin Sandoz 50 mg / 1000 mg النرويج - النرويجية - Statens legemiddelverk

vildagliptin/metformin sandoz 50 mg / 1000 mg

sandoz - københavn - vildagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg

Vildagliptin/Metformin Sandoz 50 mg / 850 mg النرويج - النرويجية - Statens legemiddelverk

vildagliptin/metformin sandoz 50 mg / 850 mg

sandoz - københavn - vildagliptin / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Vildagliptin Krka 50 mg النرويج - النرويجية - Statens legemiddelverk

vildagliptin krka 50 mg

krka, d.d. novo mesto - vildagliptin - tablett - 50 mg

Vildagliptin Accord 50 mg النرويج - النرويجية - Statens legemiddelverk

vildagliptin accord 50 mg

accord healthcare b.v. - vildagliptin - tablett - 50 mg

Eucreas الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Zomarist الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.